Literature DB >> 12712240

Nicotinamide: a jack of all trades (but master of none?).

Csaba Szabó1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12712240     DOI： 10.1007/s00134-003-1737-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  29 in total

1.  Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice.

Authors:  F J Oliver; J Ménissier-de Murcia; C Nacci; P Decker; R Andriantsitohaina; S Muller; G de la Rubia; J C Stoclet; G de Murcia
Journal:  EMBO J       Date:  1999-08-16       Impact factor: 11.598

Review 2.  Medicinal chemistry of nicotinamide in the treatment of ischemia and reperfusion.

Authors:  J Yang; L K Klaidman; J D Adams
Journal:  Mini Rev Med Chem       Date:  2002-04       Impact factor: 3.862

3.  Lipid peroxidation in nicotinamide-deficient and nicotinamide-supplemented rats.

Authors:  S S Melo; M S Meirelles; A A Jordão Júnior; H Vannucchi
Journal:  Int J Vitam Nutr Res       Date:  2000-12       Impact factor: 1.784

Review 4.  Poly(ADP-ribose) polymerase inhibitors.

Authors:  Garry J Southan; Csaba Szabó
Journal:  Curr Med Chem       Date:  2003-02       Impact factor: 4.530

Review 5.  Superoxide, superoxide dismutase and ischemic injury.

Authors:  Daniela Salvemini; Salvatore Cuzzocrea
Journal:  Curr Opin Investig Drugs       Date:  2002-06

6.  Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase.

Authors:  M Banasik; H Komura; M Shimoyama; K Ueda
Journal:  J Biol Chem       Date:  1992-01-25       Impact factor: 5.157

7.  Role of ADP-ribosylation in endothelial signal transduction and prostacyclin production.

Authors:  H Halldórsson; T Bödvarsdóttir; M Kjeld; G Thorgeirsson
Journal:  FEBS Lett       Date:  1992-12-21       Impact factor: 4.124

8.  Nicotinamide is a potent inhibitor of proinflammatory cytokines.

Authors:  J S Ungerstedt; M Blömback; T Söderström
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

9.  Protective effects of niacinamide in staphylococcal enterotoxin-B-induced toxicity.

Authors:  R D LeClaire; W Kell; S Bavari; T J Smith; R E Hunt
Journal:  Toxicology       Date:  1996-01-22       Impact factor: 4.221

Review 10.  Bench-to-bedside review: Cytopathic hypoxia.

Authors:  Mitchell P Fink
Journal:  Crit Care       Date:  2002-09-12       Impact factor: 9.097
View more
  4 in total

Review 1.  Targeting the host-pathogen interface for treatment of Staphylococcus aureus infection.

Authors:  Bonggoo Park; George Y Liu
Journal:  Semin Immunopathol       Date:  2011-11-17       Impact factor: 9.623

2.  C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice.

Authors:  Pierre Kyme; Nils H Thoennissen; Ching Wen Tseng; Gabriela B Thoennissen; Andrea J Wolf; Kenichi Shimada; Utz O Krug; Kunik Lee; Carsten Müller-Tidow; Wolfgang E Berdel; W David Hardy; Adrian F Gombart; H Phillip Koeffler; George Y Liu
Journal:  J Clin Invest       Date:  2012-08-27       Impact factor: 14.808

3.  Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner.

Authors:  Frédéric Van Gool; Mara Gallí; Cyril Gueydan; Véronique Kruys; Pierre-Paul Prevot; Antonio Bedalov; Raul Mostoslavsky; Frederick W Alt; Thibaut De Smedt; Oberdan Leo
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

4.  Nicotinamide Limits Replication of Mycobacterium tuberculosis and Bacille Calmette-Guérin Within Macrophages.

Authors:  Jason D Simmons; Glenna J Peterson; Monica Campo; Jenny Lohmiller; Shawn J Skerrett; Sorin Tunaru; Stefan Offermanns; David R Sherman; Thomas R Hawn
Journal:  J Infect Dis       Date:  2020-03-02       Impact factor: 5.226
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.